BRUKER CORPORATION Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings
BRUKER CORPORATION (BRKR) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings of $1.30 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Other Income
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings · last filed 2026-08-05
- BRUKER CORPORATION fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2026-06-30 was $1.00M, a 100.00% increase year-over-year.
- BRUKER CORPORATION fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2026-03-31 was $300.00K, a 25.00% decline year-over-year.
- BRUKER CORPORATION fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2025-12-31 was -$4.10M.
- BRUKER CORPORATION fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2025-09-30 was $700.00K.
- BRUKER CORPORATION fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for fiscal 2025 was -$2.50M, a 178.13% decline from fiscal 2024.
- BRUKER CORPORATION fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for fiscal 2024 was $3.20M, a 57.89% decline from fiscal 2023.
- BRUKER CORPORATION fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for fiscal 2023 was $7.60M.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $1.30M 10-Q · filed 2026-08-05 | -$2.80M derived: sum of 3 quarters · filed 2026-08-05 | -$2.10M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $300.00K 10-Q · filed 2026-05-07 | -$3.80M derived: sum of 2 quarters · filed 2026-05-07 | -$3.10M derived: sum of 3 quarters · filed 2026-05-07 | -$2.60M derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-12-31 | -$4.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$3.40M derived: sum of 2 quarters · filed 2026-02-27 | -$2.90M derived: sum of 3 quarters · filed 2026-02-27 | -$2.50M 10-K · filed 2026-02-27 |
| 2025-09-30 | $700.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $1.20M derived: sum of 2 quarters · filed 2025-11-05 | $1.60M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $500.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $900.00K 10-Q · filed 2025-08-06 | ||
| 2025-03-31 | $400.00K 10-Q · filed 2025-05-07 | |||
| 2024-12-31 | $3.20M 10-K · filed 2026-02-27 | |||
| 2023-12-31 | $7.60M 10-K · filed 2025-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |